Marcaine Spinal Injection, Solution
Product Images NDC 0409-1761

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Marcaine Spinal (NDC 0409-1761). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hospira Logo (Marcaine 01)

FDA Label Image

Structural Formula Bupivacaine Hydrochloride (Marcaine 02)

Chemical structure diagram of Bupivacaine Hydrochloride, the active ingredient in Marcaine Spinal 7.5 mg/mL injection solution. The structure shows the molecular arrangement including the hydrochloride and water components.*

FDA Label Image

Structural Formula Dextrose (Marcaine 03)

Chemical structure diagram depicting the molecular formula of Bupivacaine Hydrochloride in Dextrose, including the glucose ring and associated chemical groups, with a water molecule (H2O) indicated.*

FDA Label Image

Hospira Logo (Marcaine 04)

FDA Label Image

Principal Display Panel (2 mL Ampule Label)

Label for Marcaine Spinal 7.5 mg/mL injection, solution containing bupivacaine hydrochloride in dextrose, USP. The label indicates a 2 mL vial, with NDC 0409-1761-19, and specifies the product as for subarachnoid route. The label is distributed by Hospira, Inc., Lake Forest, IL, USA, and includes lot and expiration information.*

FDA Label Image

Principal Display Panel (2 mL Ampule Unit Dose Pak Label)

Marcaine Spinal 7.5 mg/mL injection label for subarachnoid use. The label states it contains bupivacaine hydrochloride in dextrose, USP. It is a 2 mL unit dose pak distributed by Hospira, Inc. with NDC 0409-1761. The label includes concentration details and indicates prescription-only status.*

FDA Label Image

Principal Display Panel (2 mL Ampule Unit Dose Pak Carton)

Packaging label for Marcaine Spinal 7.5 mg/mL injection, solution in a 2 mL ampul. The label indicates it is a sterile hyperbaric solution for spinal anesthesia containing bupivacaine hydrochloride in dextrose, USP, manufactured by Hospira, Inc. The package contains 10 ampuls in a UNI-AMP unit dose pack, with NDC 0409-1761-02, and is distributed by Hospira, Inc., Lake Forest, IL.*

FDA Label Image

Marcaine 08

Label for Marcaine Spinal 7.5 mg/mL injection, solution for subarachnoid use. Contains bupivacaine hydrochloride in dextrose injection, USP in a 2 mL container. Label includes lot/expiration code, NDC 0409-1761-18, and distributed by Hospira, Inc., Lake Forest, IL 60045 USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.